Portable/Prevention Unit
NMPA Approved in China. For early and mild dry eye disease. Provides preventive treatment for high-risk patients.
- Direct Action
Directly heats the meibomian glands from the inner eyelid surface, unaffected by individual anatomical variations.
- Precise Temperature Control
Maintains 42.5°C ± 1°C, ensuring both safety and therapeutic efficacy.
- Safe and Non-Invasive
Painless and atraumatic, with high patient comfort.
- Efficient and Convenient
Single treatment session of approximately 12 minutes.
- Compact and Lightweight
Suitable for use in a wide range of clinical and ambulatory settings.